Figure 5.PTX3 serum levels at baseline in patients with renal clear cell carcinoma before and after surgery (A) and at different Furhman grading (B), lymphnode involvement (C) and metastasis staging (D).
Figure 5 — PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma | Aging
